{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:03:44Z","timestamp":1790496224750,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Crohn's disease (CD) frequently recurs after intestinal resection. Azathioprine (AZA) and biological therapies have shown efficacy in preventing postoperative recurrence (POR). Data on POR from Middle Eastern populations is lacking. This study aimed to evaluate the rate of endoscopic POR in a cohort of CD patients who underwent ileocecal resection (ICR), and to assess the effectiveness of AZA and biological therapies in reducing the risk of disease recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We performed a retrospective cohort study on 105 CD patients followed at our center, who underwent ileal resection and were at moderate to high risk for POR. Clinical and laboratory data were collected; the primary endpoint was post ICR endoscopic recurrence at 24 months defined by Rutgeerts' score of i2 or more despite treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In total, 105 patients with Crohn's disease met our inclusion criteria; 76.2% were in remission and did not have endoscopic POR at 24 months. Further, 41.9% were on biological therapy, and 34.3% were mainly on AZA. Out of the 28.2% who had POR, approximately 15% were on biological therapies. Penetrating phenotype was the only predictive factor for decreasing POR (OR = 0.19, 95% CI: 0.04\u20130.98,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04) as identified in multiple logistic regression analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The use of biological therapies post-surgery was not superior than AZA in reducing the endoscopic POR for mod- high risk CD patients. Only penetrating behavior of the CD was associated with significantly lower risk of endoscopic recurrence. This finding is worth further investigation in more robust study designs and among larger samples of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjg.sjg_499_21","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T05:45:15Z","timestamp":1642139115000},"page":"201-208","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Rate and risk factors of postoperative endoscopic recurrence of moderate- to high-risk Crohn's disease patients - A real-world experience from a Middle Eastern cohort"],"prefix":"10.4103","volume":"28","author":[{"given":"Nahla","family":"Azzam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazed","family":"AlRuthia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla","family":"Al Thaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Almadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othman","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Altuwaijri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suliman","family":"Alshankiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulelah","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Aljebreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Regueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20240829","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/gut.33.3.331","article-title":"Natural course of Crohn's disease after ileocolic resection: Endoscopically visualised ileal ulcers preceding symptoms","volume":"33","author":"Olaison","year":"1992","journal-title":"Gut"},{"key":"R2-6-20240829","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.gtc.2017.05.003","article-title":"Epidemiology, natural history, and risk stratification of Crohn's disease","volume":"46","author":"Aniwan","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"R3-6-20240829","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MOG.0000000000000638","article-title":"Postoperative Crohn's disease management","volume":"36","author":"Barnes","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"key":"R4-6-20240829","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00000658-200001000-00006","article-title":"Risk factors for surgery and postoperative recurrence in Crohn's disease","volume":"231","author":"Bernell","year":"2000","journal-title":"Ann Surg"},{"key":"R5-6-20240829","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/gut.29.5.588","article-title":"Perforating and non-perforating indications for repeated operations in Crohn's disease: Evidence for two clinical forms","volume":"29","author":"Greenstein","year":"1988","journal-title":"Gut"},{"key":"R6-6-20240829","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0016-5085(98)70191-X","article-title":"Risk factors for early postoperative recurrence of Crohn's disease","volume":"115","author":"Lautenbach","year":"1998","journal-title":"Gastroenterology"},{"key":"R7-6-20240829","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0016-5085(94)90697-1","article-title":"Smoking habits and recurrence in Crohn's disease","volume":"106","author":"Cottone","year":"1994","journal-title":"Gastroenterology"},{"key":"R8-6-20240829","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/ibd.20915","article-title":"Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: A prospective pilot study","volume":"15","author":"Yamamoto","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"R9-6-20240829","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1586\/egh.12.45","article-title":"The evolving management of postoperative Crohn's disease","volume":"6","author":"Hashash","year":"2012","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R10-6-20240829","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"R11-6-20240829","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J Crohns Colitis"},{"key":"R12-6-20240829","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","article-title":"Predictability of the postoperative course of Crohn's disease","volume":"99","author":"Rutgeerts","year":"1990","journal-title":"Gastroenterology"},{"key":"R13-6-20240829","first-page":"598","article-title":"Risk factors for postoperative recurrence of Crohn's disease with emphasis on surgical predictors","volume":"30","author":"Gklavas","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"R14-6-20240829","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/j.gastro.2016.10.039","article-title":"American gastroenterological association institute technical review on the management of Crohn's disease after surgical resection","volume":"152","author":"Regueiro","year":"2017","journal-title":"Gastroenterology"},{"key":"R15-6-20240829","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11894-016-0499-8","article-title":"A practical approach to preventing postoperative recurrence in Crohn's disease","volume":"18","author":"Hashash","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"R16-6-20240829","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(14)61908-5","article-title":"Crohn's disease management after intestinal resection: A randomised trial","volume":"385","author":"De Cruz","year":"2015","journal-title":"Lancet"},{"key":"R17-6-20240829","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.gastro.2008.10.051","article-title":"Infliximab prevents Crohn's disease recurrence after ileal resection","volume":"136","author":"Regueiro","year":"2009","journal-title":"Gastroenterology"},{"key":"R18-6-20240829","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.gastro.2004.06.002","article-title":"Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial","volume":"127","author":"Hanauer","year":"2004","journal-title":"Gastroenterology"},{"key":"R19-6-20240829","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/gut.2009.194159","article-title":"Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: Efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial","volume":"59","author":"Reinisch","year":"2010","journal-title":"Gut"},{"key":"R20-6-20240829","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/ecco-jcc\/jjz047","article-title":"Low-dose metronidazole is associated with a decreased rate of endoscopic recurrence of Crohn's disease after ileal resection: A retrospective cohort study","volume":"13","author":"Glick","year":"2019","journal-title":"J Crohns Colitis"},{"key":"R21-6-20240829","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ibd.20359","article-title":"Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: Results of a prospective, observational, long-term follow-up study","volume":"14","author":"Dom\u00e8nech","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R22-6-20240829","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1001\/archinte.167.16.1804","article-title":"Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease","volume":"167","author":"Sorrentino","year":"2007","journal-title":"Arch Intern Med"},{"key":"R23-6-20240829","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1053\/j.gastro.2016.02.072","article-title":"Infliximab reduces endoscopic, but not clinical, recurrence of Crohn's disease after ileocolonic resection","volume":"150","author":"Regueiro","year":"2016","journal-title":"Gastroenterology"},{"key":"R24-6-20240829","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.crohns.2012.02.012","article-title":"Adalimumab for the prevention and\/or treatment of post-operative recurrence of Crohn's disease: A prospective, two-year, single center, pilot study","volume":"6","author":"Papamichael","year":"2012","journal-title":"J Crohns Colitis"},{"key":"R25-6-20240829","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/apt.13353","article-title":"Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients-A POCER study analysis","volume":"42","author":"De Cruz","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R26-6-20240829","doi-asserted-by":"crossref","first-page":"642","DOI":"10.17235\/reed.2016.4483\/2016","article-title":"Adalimumab versus infliximab in treating post-operative recurrence of Crohn's disease: A national cohort study","volume":"108","author":"Preda","year":"2016","journal-title":"Rev Esp Enferm Dig"},{"key":"R27-6-20240829","first-page":"32","article-title":"Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission","volume":"39","author":"Kane","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"R28-6-20240829","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1046\/j.1365-2168.1999.01189.x","article-title":"Smoking is a predictive factor for outcome after colectomy and ileorectal anastomosis in patients with Crohn's colitis","volume":"86","author":"Yamamoto","year":"1999","journal-title":"Br J Surg"},{"key":"R29-6-20240829","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjsurg.2003.11.007","article-title":"Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence","volume":"187","author":"Ryan","year":"2004","journal-title":"Am J Surg"},{"key":"R30-6-20240829","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10350-008-9348-7","article-title":"Risk factors for surgical recurrence after ileocolic resection of Crohn's disease","volume":"51","author":"Unkart","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"R31-6-20240829","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"R32-6-20240829","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10350-004-6186-0","article-title":"Recurrence after abdominal surgery for Crohn's disease: Relationship to disease site and surgical procedure","volume":"45","author":"Borley","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"R33-6-20240829","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.crohns.2014.07.010","article-title":"Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003-2011\u2014A Danish population-based cohort study","volume":"8","author":"Vester-Andersen","year":"2014","journal-title":"J Crohns Colitis"},{"key":"R34-6-20240829","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/ibd.20872","article-title":"Recurrence patterns after first resection for stricturing or penetrating Crohn's disease","volume":"15","author":"Sachar","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"R35-6-20240829","first-page":"152","article-title":"The impact of clinical types of disease manifestation on the risk of early postoperative recurrence in Crohn's disease","volume":"48","author":"Hofer","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"R36-6-20240829","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1572-0241.2007.01548.x","article-title":"A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease","volume":"103","author":"Simillis","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R37-6-20240829","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF02234180","article-title":"Perforating ileocecal Crohn's disease does not carry a high risk of recurrence but usually re-presents as perforating disease","volume":"42","author":"Yamamoto","year":"1999","journal-title":"Dis Colon Rectum"},{"key":"R38-6-20240829","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/SLA.0000000000003531","article-title":"Penetrating Crohn disease is not associated with a higher risk of recurrence after surgery: A prospective nationwide cohort conducted by the Getaid Chirurgie group","volume":"270","author":"Maggiori","year":"2019","journal-title":"Ann Surg"},{"key":"R39-6-20240829","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","article-title":"3rd European Evidence-based Consensus on the diagnosis and management of Crohn's disease 2016: Part 2: Surgical management and special Situations","volume":"11","author":"Gionchetti","year":"2017","journal-title":"J Crohns Colitis"},{"key":"R40-6-20240829","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00000658-199109000-00006","article-title":"Primary and recurrent Crohn's disease. Experience with 1379 patients","volume":"214","author":"Michelassi","year":"1991","journal-title":"Ann Surg"},{"key":"R41-6-20240829","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1463-1318.2006.01202.x","article-title":"Early symptomatic recurrence after intestinal resection in Crohn's disease is unpredictable","volume":"9","author":"Kurer","year":"2007","journal-title":"Colorectal Dis"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_499_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:49:05Z","timestamp":1787755745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_499_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_499_21","relation":{},"ISSN":["1319-3767"],"issn-type":[{"value":"1319-3767","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}